Therapeutic strategies to increase adiponectin concentrations may serve as a therapeutic tool for tumor patients [14,19,75] and treatment with adiponectin may modulate the poor prognosis of cancer patients [6]. This evidence concerns the gene ADIPOQ and cancer.